Pharma Sector

On February 6, 2023, Cipla informed exchanges that I-T department officials had searched some of company offices and manufacturing units.

According to the terms of the agreement, Lupin may receive up to $84 million in total payment based on future dependent milestones.

According to the corporation, the observations have no influence on business continuity or supplies to the US market.

The inspection finished with no observations, and the facility was classified as "No Action Indicated" (NAI).

It has entered into a share purchase agreement to acquire a 100% equity stake in Chalasani Hospitals Pvt Ltd.

Currently, more than 70 Kaya skin clinics nationwide and some of the top e-commerce platforms carry Kaya's products.

The warning letter detailed substantial violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals at the facility.

Fenofibrate is a drug used to treat high cholesterol and triglyceride levels in the blood, which helps with cardiovascular health management.

According to reports, the sanctions were imposed as a result of their participation in "pay-for-delay" arrangements from 2005 to 2007.

Earlier on June 25, about 3.6 lakh shares of Alkem Laboratories Ltd were traded in a block deal worth ₹117.8 Crore before the market opened.